Ultra‐Tiny Scale Technology for iPSC‐Based Cardiac Tissue Engineering
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202502891 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Chaeyeon Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Convergence Biosystems Engineering, Chonnam National University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Tissue Engineering, Induced Pluripotent Stem Cells, Myocytes, Cardiac. Die Arbeit nennt 116 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea government.
Abstract (Originalsprache)
Integration of nanoscale technologies into cardiac tissue engineering significantly advances strategies for enhancing the maturation and functional performance of human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs). However, despite their significant potential, hiPSC‐CMs exhibit structural and functional immaturity that limits their therapeutic application. Nanoscale engineered scaffolds offer precise control over the cellular microenvironment, providing biophysical cues through topographical features that significantly influence cell alignment, differentiation, and maturation. Among these, ultra‐tiny nanoscale engineering approaches have emerged as a transformative strategy to more accurately replicate the microenvironmental cues essential for hiPSC‐CMs maturation. Therefore, this review aims to examine recent advancements in nanoscale technologies, focusing on promoting the structural and functional maturation of hiPSC‐CMs to mimic native myocardial microenvironment. It explores the role of various nanostructures and nanobridge scaffolds in enhancing microenvironmental mimicry and delivering biophysical stimulation including mechanical and electrical cues to address persistent challenges associated with hiPSC‐CMs immaturity. Additionally, this review emphasizes the application of nanotechnology assisted hiPSC‐CMs models in advancing cardiac tissue regeneration, drug screening and toxicity assessment, and disease modeling. Finally, it evaluates the commercialization potential and current limitations of nanoengineered cardiac regeneration platforms, focusing on scalability, integration, and physiological relevance to assess their transformative effect for cardiac regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Convergence Biosystems Engineering, Chonnam National University, Gwangju, Republic of Korea.
- Department of Rural and Biosystems Engineering, Chonnam National University, Gwangju, Republic of Korea.
- Interdisciplinary Program in IT-Bio Convergence System, Chonnam National University, Gwangju, Republic of Korea.
- Institute of Nano-Stem Cell Therapeutics, NANOBIOSYSTEM Co., Ltd, Gwangju, Republic of Korea.
ORCID-Profile: Jangho Kim
Förderung
- National Research Foundation of Korea
- Korea government
Zitieren
APA
Park, C., Kim, W., Sharma, H., Kim, D., Lee, S., & Kim, J. (2025). Ultra‐Tiny Scale Technology for iPSC‐Based Cardiac Tissue Engineering. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502891
Vancouver
Park C, Kim W, Sharma H, Kim D, Lee S, Kim J. Ultra‐Tiny Scale Technology for iPSC‐Based Cardiac Tissue Engineering. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202502891
BibTeX
@article{Park2025,
author = {Park, Chaeyeon and Kim, Woochan and Sharma, Harshita and Kim, Dream and Lee, Shinyull and Kim, Jangho},
title = {Ultra‐Tiny Scale Technology for iPSC‐Based Cardiac Tissue Engineering},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202502891}
}
EUVIMED